Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burr, Egan, Deleage & Co. (BEDCO) was a pioneering venture capital firm founded in 1979 that played a foundational role in the early development of the biotechnology and information technology industries. The firm is best known for its early-stage investments in industry-defining biotech companies such as Biogen, Chiron, and Cephalon. Operating with a bi-coastal presence in Boston and San Francisco, BEDCO provided critical capital and strategic guidance to emerging healthcare and tech startups during the 1980s and early 1990s. In 1995, the firm's partners transitioned to form new entities, with the life sciences team founding Alta Partners and the communications team forming Alta Communications. BEDCO remains a significant name in the history of life science venture investing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Burr, Egan, Deleage & Co..